Suppr超能文献

miR-98-5p通过USP44/CTCFL轴影响胃癌细胞增殖、迁移和侵袭的机制

Mechanism of miR-98-5p in gastric cancer cell proliferation, migration, and invasion through the USP44/CTCFL axis.

作者信息

Zhang Kangkang, Zhao Jinjiang, Bi Zhibin, Feng Yafei, Zhang Huipeng, Zhang Jinjie, Qin Xiaowei, Zhao Yanbo, Niu Ruilong, Mei Xianghuang, He Zhipeng, Yang Jingcheng, Lv Jiake, Guo Wei

机构信息

Department of gastrointestinal surgery, Changzhi Medical College Affiliated Heji Hospital, No. 271 Taihang East Street, Luzhou District, Changzhi, Shanxi 046000, China.

出版信息

Toxicol Res (Camb). 2024 Mar 15;13(2):tfae040. doi: 10.1093/toxres/tfae040. eCollection 2024 Apr.

Abstract

OBJECTIVES

Gastric cancer (GC) is the leading digestive malignancy with high incidence and mortality rate. microRNAs (miRs) play an important role in GC progresssion. This study aimed to investigate the effect of miR-98-5p on proliferation, migration, and invasion of GC cells.

METHODS

The expression levels of miR-98-5p, ubiquitin specific peptidase 44 (USP44), and CCCTCbinding factor-like (CTCFL) in GC tissues and cells were identified using reversetranscription quantitative polymerase chain reaction and Western blot assay. The relationship between miR-98-5p expression/USP44 and the clinicopathological features in GC patients was analyzed. GC cell proliferation, invasion, and migration were evaluated by cell counting kit-8 and clone formation assays and Transwell assays. The bindings of miR-98-5p to USP44 and USP44 to CTCFL were examined using dualluciferase assay and co-immunoprecipitation. GC cells were treated with MG132 and the ubiquitination level of CTCFL was examined using ubiquitination assay. Rescue experiments were performed to verify the roles of USP44 and CTCFL in GC cells.

RESULTS

miR-98-5p was downregulated in GC. miR-98-5p overexpression inhibited the proliferation, migration, and invasion of GC cells. miR-98-5p inhibited USP44 expression. USP44 bound to CTCFL and limited ubiquitination degradation of CTCFL. Overexpression of USP44 and CTCFL attenuated the inhibitory effects of miR-98-5p overexpression on GC cell progression.

CONCLUSION

miR-98-5p overexpression limited USP44-mediated CTCFL deubiquitination, and suppressed CTCFL expression, mitigating GC cell proliferation, migration, and invasion.

摘要

目的

胃癌(GC)是主要的消化系统恶性肿瘤,发病率和死亡率高。微小RNA(miR)在胃癌进展中起重要作用。本研究旨在探讨miR-98-5p对胃癌细胞增殖、迁移和侵袭的影响。

方法

采用逆转录定量聚合酶链反应和蛋白质免疫印迹法检测胃癌组织和细胞中miR-98-5p、泛素特异性肽酶44(USP44)和CCCTC结合因子样蛋白(CTCFL)的表达水平。分析miR-98-5p表达/USP44与胃癌患者临床病理特征之间的关系。通过细胞计数试剂盒-8、克隆形成实验和Transwell实验评估胃癌细胞的增殖、侵袭和迁移能力。采用双荧光素酶报告基因实验和免疫共沉淀实验检测miR-98-5p与USP44以及USP44与CTCFL之间的结合。用MG132处理胃癌细胞,采用泛素化实验检测CTCFL的泛素化水平。进行挽救实验以验证USP44和CTCFL在胃癌细胞中的作用。

结果

miR-98-5p在胃癌中表达下调。miR-98-5p过表达抑制胃癌细胞的增殖、迁移和侵袭。miR-98-5p抑制USP44表达。USP44与CTCFL结合并限制CTCFL的泛素化降解。USP44和CTCFL过表达减弱了miR-98-5p过表达对胃癌细胞进展的抑制作用。

结论

miR-98-5p过表达限制USP44介导的CTCFL去泛素化,抑制CTCFL表达,减轻胃癌细胞的增殖、迁移和侵袭。

相似文献

1
Mechanism of miR-98-5p in gastric cancer cell proliferation, migration, and invasion through the USP44/CTCFL axis.
Toxicol Res (Camb). 2024 Mar 15;13(2):tfae040. doi: 10.1093/toxres/tfae040. eCollection 2024 Apr.
4
inhibits gastric cancer progression the serpin family E member 1- extracellular signal-regulated kinase-1/2 axis.
World J Gastrointest Oncol. 2024 May 15;16(5):2123-2140. doi: 10.4251/wjgo.v16.i5.2123.
6
Lidocaine Suppresses Gastric Cancer Development Through Circ_ANO5/miR-21-5p/LIFR Axis.
Dig Dis Sci. 2022 Jun;67(6):2244-2256. doi: 10.1007/s10620-021-07055-6. Epub 2021 May 29.
7
Knockdown of Circ_0081143 Mitigates Hypoxia-Induced Migration, Invasion, and EMT in Gastric Cancer Cells Through the miR-497-5p/EGFR Axis.
Cancer Biother Radiopharm. 2021 May;36(4):333-346. doi: 10.1089/cbr.2019.3512. Epub 2020 Jul 15.
8
Circ_0027599 elevates RUNX1 expression via sponging miR-21-5p on gastric cancer progression.
Eur J Clin Invest. 2021 Nov;51(11):e13592. doi: 10.1111/eci.13592. Epub 2021 May 25.
9
The miR-155-5p/ axis inhibits the progression of gastric cancer via the mTOR pathway.
Transl Cancer Res. 2025 Feb 28;14(2):1375-1387. doi: 10.21037/tcr-2025-8. Epub 2025 Feb 26.
10
MiR-145-5p suppresses the proliferation, migration and invasion of gastric cancer epithelial cells via the NOD_LIKE_RECEPTOR axis.
Cancer Cell Int. 2020 Aug 28;20:416. doi: 10.1186/s12935-020-01483-6. eCollection 2020.

本文引用的文献

1
Clinical application study on miR-98-5p as a prognostic biomarker in hepatocellular carcinoma.
Clin Res Hepatol Gastroenterol. 2023 Feb;47(2):102077. doi: 10.1016/j.clinre.2023.102077. Epub 2023 Jan 6.
2
Insight into the physiological and pathological roles of USP44, a potential tumor target (Review).
Oncol Lett. 2022 Nov 1;24(6):455. doi: 10.3892/ol.2022.13575. eCollection 2022 Dec.
4
Molecular and Circulating Biomarkers of Gastric Cancer.
Int J Mol Sci. 2022 Jul 8;23(14):7588. doi: 10.3390/ijms23147588.
5
The Role of MicroRNAs in Hyperlipidemia: From Pathogenesis to Therapeutical Application.
Mediators Inflamm. 2022 Jun 17;2022:3101900. doi: 10.1155/2022/3101900. eCollection 2022.
6
PITPNA-AS1/miR-98-5p to Mediate the Cisplatin Resistance of Gastric Cancer.
J Oncol. 2022 May 7;2022:7981711. doi: 10.1155/2022/7981711. eCollection 2022.
9
A Novel miR-98 Negatively Regulates the Resistance of Endometrial Cancer Cells to Paclitaxel by Suppressing ABCC10/MRP-7.
Front Oncol. 2021 Dec 7;11:809410. doi: 10.3389/fonc.2021.809410. eCollection 2021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验